Drug Chatter -- Get concise, cited information on drugs using AI GPT chat

Ask Questions, Get Industry Insights … Instantly


Save time and get answers to complex questions with AI chat

Recent Questions

Brenzavvy discontinuation?
Guselkumab patent expiration?
Mebendazole 100mg price?
Dabrafenib patent expiration?
Alogliptin benzoate cost?

When was camzyos approved?

See the DrugPatentWatch profile for camzyos

When did the FDA approve Camzyos?

Camzyos (mavacamten) was approved by the FDA in April 2022. [1]

What was the approval for?

Camzyos is approved for adults with symptomatic NYHA class II–III obstructive hypertrophic cardiomyopathy (HCM). [1]

Sources

  1. DrugPatentWatch.com – Camzyos (mavacamten) Approval Information


Other Questions About Camzyos :

Are there generic versions or alternatives to camzyos? Camzyos generic alternatives? Camzyos reviews? Camzyos price? Where is camzyos manufactured? Camzyos? Camzyos mavacamten patent exclusivity?